- Home
- /
- Treatment
- /
- Page 129
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Dimethylsulfoxide | Topical treatment for the prevention of soft tissue injury following extravastion of cytotoxic drugs | Cancer Technologies, Inc.;7301 East 22nd Street, Suite 10E;Tucson, Arizona, 85710 | April 15, 1997 | |
Levocarnitine | Zidovudine-induced mitochondrial myopathy | Leadiant Biosciences, Inc.;9841 Washingtonian Blvd, Suite 500;Gaithersburg, Maryland, 20878 | April 7, 1997 | |
MART-1 adenoviral gene therapy for malignant melanoma | Metastatic melanoma | Genzyme Corporation;500 Kendall Street;Cambridge, Massachusetts, 01701 | March 28, 1997 | |
Gp100 adenoviral gene therapy | Metastatic melanoma | Genzyme Corporation;500 Kendall Street;Cambridge, Massachusetts, 02142 | March 25, 1997 | |
Paclitaxel | AIDS-related Kaposi's sarcoma | Bristol-Myers Squibb Pharmaceutical Research Institute;5 Research Parkway, P.O. Box 5100;Wallingford, Connecticut, 06492 | March 25, 1997 | |
Beta alethine | Metastatic melanoma | Dovetail Technologies, Inc.;Bldg. 337, Paint Branch Drive;College Park, Maryland, 20742 | March 24, 1997 | |
8 Cyclopentyl 1,3-dipropylxanthine | Cystic fibrosis | SciClone Pharmaceuticals, Inc.;901 Mariner's Island Boulevard;San Mateo, California, 94404 | March 24, 1997 | |
Beta alethine | Multiple myeloma | Dovetail Technologies, Inc.;Bldg. 337, Paint Branch Drive;College Park, Maryland, 20742 | March 24, 1997 | |
Poly-ICLC | Primary brain tumors | Oncovir;3202 Cleveland Avenue N.W.;Washington, District of Columbia, 20008 | March 17, 1997 | |
Porfiromycin | Cervical cancer | Boehringer Ingelheim Pharmaceuticals, Inc.;900 Ridgebury Road, PO Box 368;Ridgefield, Connecticut, 06877 | March 13, 1997 | |
Chlorobutanol/propylene glycol/hydrochloric acid | Patulous eustachian tube | Ear Foundation;2420 Castillo Street, Suite 100;Santa Barbara, California, 93105 | February 18, 1997 | |
Lepirudin | Heparin-associated thrombocytopenia type II | Hoechst Marion Roussel;Frankfurt am Main, P.O. Box 1140;Marburg | February 13, 1997 | |
Dehydroepiandrosterone sulfate sodium | Serious burns requiring hospitalization | Pharmadigm, Inc.;2401 Foothill Drive;Salt Lake City, Utah, 84109 | January 29, 1997 | |
Dehydroepiandrosterone sulfate sodium | To accelerate the re-epithelialization of donor sites in those hospitalized burn patients who must undergo autologous skin grafting | Pharmadigm, Inc.;2401 Foothill Drive;Salt Lake City, Utah, 84109 | January 28, 1997 | |
Enadoline hydrochloride | Severe head injury | Warner-Lambert Company;Parke-Davis Pharmaceutical Research Division, 2800 Plymouth Road;Ann Arbor, Michigan, 48105 | January 28, 1997 | |
9-cis-retinoic acid | Prevention of retinal detachment due to proliferative vitreoretinopathy | Allergan, Inc.;2525 Dupont Drive, P.O. Box 19534;Irvine, California, 92623 | January 2, 1997 | |
Oprelvekin | Prevention of severe chemotherapy-induced thrombocytopenia | Genetics Institute, Inc.;87 Cambridge Park Drive;Cambridge, Massachusetts, 02140 | December 17, 1996 | |
Porcine fetal neural dopaminergic cells and/or precursors aseptically prepared and coated with anti-MHC-1 Ab for intracerebral implantation | Hoehn and Yahr stage 4 and 5 Parkinson's disease | Diacrin/Genzyme LLC;One Kendall Square;Cambridge, Massachusetts, 02129 | December 17, 1996 | |
Porcine fetal neural dopaminergic cells and/or precursors aseptically prepared for intracerebral implantation. | Hoehn and Yahr stage 4 and 5 Parkinson's disease | Diacrin/Genzyme LLC;One Kendall Square;Cambridge, Massachusetts, 02139 | December 17, 1996 | |
Nitazoxanide | Cryptosporidiosis | Romark Laboratories, L.C.;6200 Courtney Campbell Causeway, Suite 880;Tampa, Florida, 33607 | December 12, 1996 | |
Liposomal amphotericin B | Histoplasmosis | Fujisawa USA, Inc.;3 Parkway North Center;Deerfield, Illinois, 60015 | December 10, 1996 | |
Porcine fetal neural gabaergic cells and/or precursors aseptically prepared and coated with anti-MHC-1 Ab for intracerebral implantation | Huntington disease | Diacrin/Genzyme LLC;One Kendall Square;Cambridge, Massachusetts, 02129 | December 10, 1996 | |
Porcine fetal neural gabaergic cells and/or precursors aseptically prepared for intracerebral implantation for Huntington’s disease. | Huntington disease | Diacrin/Genzyme LLC;One Kendall Square;Cambridge, Massachusetts, 02139 | December 10, 1996 | |
N-acetyl-procainamide | Prevention of life-threatening ventricular arrhythmias in patients with documented procainamide-induced lupus | NAPA of the Bahamas;3560 Pennsylvania Avenue, Suite 7;Dubuque, Iowa, 52002 | December 10, 1996 | |
Liposomal amphotericin B | Cryptococcal meningitis | Fujisawa USA, Inc.;3 Parkway North Center;Deerfield, Illinois, 60015 | December 10, 1996 |